ClinicalTrials.gg
CompletedNCT04706052Updated Jan 13, 2021

Facial Nerve Morbidity After Superficial Parotidectomy in the Absence of Nerve Conductor

An observational study in Facial Nerve Injuries and Adenoma, Pleomorphic, sponsored by Liaquat University of Medical & Health Sciences. Completed at 1 site in Pakistan. Per ClinicalTrials.gov, last updated 2021-01-13.

Sponsored by Liaquat University of Medical & Health Sciences · Observational

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Retrospective
Enrollment
101
Sex
All
01

Study summary

In this single-centre, cross-sectional case series, the investigators aim to evaluate the incidence of facial nerve injury in patients undergoing superficial parotidectomy in the absence of nerve conductor. Data to be collected retrospectively from a prospectively maintained database of consecutive patients, at the Department of Surgery, Liaquat University of Medical and Health Sciences Jamshoro, Pakistan. The sample size was calculated as 101.

Read the detailed description

In this single-centre, cross-sectional case series, the investigators aim to evaluate the incidence of facial nerve injury in partcipants undergoing superficial parotidectomy in the absence of nerve conductor. The institutional Research Ethics Committee has approved the study. Data to be collected retrospectively from a prospectively maintained database, at the Department of Surgery, Liaquat University of Medical and Health Sciences Jamshoro, Pakistan. The data period to be over a period of nine years that is from 1st January 2012 till August 2020. The sample size was calculated using the WHO sample size calculator and taking disease prevalence as 7.1 with CI 95%, which turned out to be 101. All the patients with pleomorphic adenoma irrespective of age and gender were included. To control any chance of bias, one of the members of researchers as part of the team who operated upon these patients. The primary outcome was the incidence of temporary or permanent facial nerve injury, while secondary outcomes were wound infection, seroma, hematoma, Frey's syndrome, salivary fistula and disfigured scar. Temporary facial nerve injury was defined as a feature of facial nerve palsy with full recovery to regular activity within six months. Permanent facial nerve injury was defined as any facial nerve dysfunction lasting beyond six months of operation. The data was recorded on a predesigned Performa, and patients' confidentiality was maintained assigning codes to each case known only to researchers. The data was calculated using SPSS version 23. Values of mean and standard deviation were calculated for continuous variables, whereas frequencies were calculated for categorical data.

02

Conditions studied

  • Facial Nerve Injuries
  • Adenoma, Pleomorphic

Keywords

  • Superficial Parotidectomy
  • Facial Nerve Injuries
  • Adenoma, Pleomorphic
03

In context

Lead sponsor

Liaquat University of Medical & Health Sciences is the lead sponsor of 57 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

All the suitable and selected patients consented for surgery with an explanation of procedure-related complications. Superficial parotidectomy was a standard surgical procedure for these selected patients with previously untreated pleomorphic adenoma.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • All the patients with pleomorphic adenoma irrespective of age and gender were included

Exclusion criteria

Exclusion Criteria:

  • Patients with recurrent disease or unwilling for participation were excluded
05

Study design

Observational model
Case-control
Time perspective
Retrospective
Enrollment
101 participants (actual)
Patient registry
No

Groups and cohorts

  • Superficial Parotidectomy Patient

    All the patients with pleomorphic adenoma irrespective of age and gender who underwent Superficial parotidectomy

    Other: Superficial Parotidectomy

Interventions

  • OtherSuperficial Parotidectomy

    Classical procedure for pleomorphic adenoma of the parotid gland is superficial parotidectomy around the world. This study only observed the outcome with reference to facial nerve morbidity

06

What researchers measure

Primary outcomes

  1. incidence of temporary or permanent facial nerve injury

    Temporary facial nerve injury was defined as a feature of facial nerve palsy with full recovery to regular activity within six months. Permanent facial nerve injury was defined as any facial nerve dysfunction lasting beyond six months of operation.

    Time frame: 12 months

Secondary outcomes

  1. wound infection

    Rate of postoperative surgical site infection will be calculated

    Time frame: 12 months

  2. seroma

    Rate of postoperative formation of seroma (non-infected collection) occurring after superficial parotidectomy will be calculated

    Time frame: 12 months

  3. hematoma

    Rate of postoperative incidence of hematoma/ clot formation at the operative site will be calculated

    Time frame: 12 months

  4. Frey's syndrome

    Frey's syndrome is the result of misdirected regeneration of parasympathetic fibres connecting with regenerating sympathetic nerve leading to facial sweating and flushing during times of eating food. Rate of occurrence of Frey's syndrome will be calculated to understand its incidence.

    Time frame: 12 months

  5. salivary fistula

    Salivary fistula is abnormal communication between skin and remaining gland. Its rate of occurrence will be calculated during postoperative period after superficial parotidectomy.

    Time frame: 12 months

  6. disfigured scar

    The number of participants developing cosmetically bad scar will be notified and data calculated.

    Time frame: 12 months

07

Study locations

1 site
  • Fazila Hashmi
    Jāmshoro, Sindh, Pakistan
08

References and documents

Publications

  • Siddiqui AH, Shakil S, Rahim DU, Shaikh IA. Post parotidectomy facial nerve palsy: A retrospective analysis. Pak J Med Sci. 2020 Jan-Feb;36(2):126-130. doi: 10.12669/pjms.36.2.1706. PubMed 32063945 ↗
  • Bittar RF, Ferraro HP, Ribas MH, Lehn CN. Facial paralysis after superficial parotidectomy: analysis of possible predictors of this complication. Braz J Otorhinolaryngol. 2016 Jul-Aug;82(4):447-51. doi: 10.1016/j.bjorl.2015.08.024. Epub 2015 Dec 19. PubMed 26777078 ↗
  • Al-Qahtani KH, AlQahtani FM, Muqat MM, AlQahtani MS, Al-Qannass AM, Islam T, Alharbi J, Sebaih H, Alqarni M, Hakami H. A new landmark for the identification of the facial nerve during parotid surgery: A cadaver study. Laryngoscope Investig Otolaryngol. 2020 Jul 28;5(4):689-693. doi: 10.1002/lio2.431. eCollection 2020 Aug. PubMed 32864440 ↗
  • Saha S, Pal S, Sengupta M, Chowdhury K, Saha VP, Mondal L. Identification of facial nerve during parotidectomy: a combined anatomical & surgical study. Indian J Otolaryngol Head Neck Surg. 2014 Jan;66(1):63-8. doi: 10.1007/s12070-013-0669-z. Epub 2013 Jul 24. PubMed 24605304 ↗
  • Gaillard C, Perie S, Susini B, St Guily JL. Facial nerve dysfunction after parotidectomy: the role of local factors. Laryngoscope. 2005 Feb;115(2):287-91. doi: 10.1097/01.mlg.0000154735.61775.cd. PubMed 15689752 ↗

Individual participant data

Plan to share: Undecided

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Ran from Jan 2012 to primary completion in Aug 2020, 103 months.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 9, 2021
First posted
Jan 12, 2021
StartActual
Jan 2012
Primary completionActual
Aug 2020
CompletionActual
Jan 2021
Last update
Jan 13, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 13, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04706052
Lead sponsor
Liaquat University of Medical & Health Sciences
Responsible party
Fazila Hashmi (Assistant Professor, Liaquat University of Medical & Health Sciences) — Principal investigator
First posted
Jan 12, 2021
Start date
Jan 2012
Primary completion
Aug 2020
Completion
Jan 2021
Last update
Jan 13, 2021

Study contacts

Fazila Hashmi, FCPS
principal investigator · Liaquat University of Medical and Health Sciences Jamshoro Pakistan

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion